Skip to content

Clinical trials

Phase 2 Epilepsy trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Phase: Phase 2 Country / region: China Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20171
20182
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda2
National Institute on Drug Dependence, China1
Peking Union Medical College Hospital1
UCB BIOSCIENCES, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy5
Epilepsies, Myoclonic2
Lennox Gastaut Syndrome2
Seizures2
Tuberous Sclerosis2
Brain Diseases1
Central Nervous System Diseases1
Cognitive Dysfunction1
Hypoxia-Ischemia, Brain1
Malformations of Cortical Development1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.